DDrare: Database of Drug Development for Rare Diseases

Searched query = "Hemiconvulsion hemiplegia epilepsy syndrome", "One side convulsions", "Hemiplegia", "Epilepsy syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Drug = 4cc of lidocaïne®; 9060X; BOTOX; BOTULINUM TOXIN TYPE A; Baclofen; Balance; Botox; Botulinum toxin; Botulinum toxin A; Botulinum toxin type A; Brivaracetam; Diagnostic Test: Nociceptor flexor reflex; Diagnostic Test: gait analysis; Edonerpic; Gradient; HC-58; Lacosamide; MEOPA; Medicinal air; Melatonin; Other: Review of past medical history, clinical exam, and electroencephalogram, polysomnography and urine samples of melatonin and pupillometry.; Other: The patients' parents have to complete the VINELAND II adaptive behavior scales scoring, The Sleep Disturbance Scale for Children (SDSC) and Horne & Ostberg Circadian Typology Questionnaire; Oxybate; Padsevonil; Placebo; Procedure: upper limb muscle block; SPM927; Sodium Oxybate; Sodium oxybate; T-817MA; Time delay treatment of botulinum toxin; Triheptanoin; Ucb 34714

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00632528 (ClinicalTrials.gov)	March 2008	28/2/2008	MEOPA to Improve Physical Therapy Results After Multilevel Surgery	Evaluation of the Efficacy of MEOPA Used to Obtain Better ROM Immediately After Multilevel Surgery in Children With Spastic Diplegia, Quadriplegia or Hemiplegia.	Cerebral Palsy;Spastic Diplegia;Quadriplegia;Hemiplegia	Drug: MEOPA;Drug: Medicinal air	Assistance Publique - Hôpitaux de Paris	NULL	Completed	6 Years	20 Years	Both	64	Phase 3	France

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT00632528
(ClinicalTrials.gov)

March 2008

28/2/2008

MEOPA to Improve Physical Therapy Results After Multilevel Surgery

Evaluation of the Efficacy of MEOPA Used to Obtain Better ROM Immediately After Multilevel Surgery in Children With Spastic Diplegia, Quadriplegia or Hemiplegia.

Cerebral Palsy;Spastic Diplegia;Quadriplegia;Hemiplegia

Drug: MEOPA;Drug: Medicinal air

Assistance Publique - Hôpitaux de Paris

NULL

Completed

6 Years

20 Years

Both

Phase 3

France